Skip to main content

Table 5 Associations between pre-DM and T2DM with TG/HDL-C according to sex

From: Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China

Variables

Model 1a

Model 2b

Pre-DM

T2DM

Pre-DM

T2DM

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

TG/HDL-C

 Male

  Total

1.16 (1.12–1.19)**

1.28 (1.24–1.32)**

1.17 (1.13–1.21) **

1.30 (1.26–1.34) **

  T1

Reference

Reference

Reference

Reference

  T2

1.20 (1.08–1.34) **

1.38 (1.26–1.51) **

1.22 (1.09–1.35) **

1.45 (1.32–1.60) **

  T3

1.51 (1.35–1.68) **

2.37 (2.16–2.60) **

1.54 (1.38–1.72) **

2.56 (2.32–2.82) **

  P trend

 < 0.001

 < 0.001

 < 0.001

 < 0.001

  Low

Reference

Reference

Reference

Reference

  High

1.62 (1.37–1.90) **

2.65 (2.31–3.05) **

1.63 (1.38–1.93) **

2.70 (2.35–3.11) **

 Female

  Total

1.26 (1.21–1.32) **

1.50 (1.44–1.56) **

1.27 (1.21–1.33) **

1.49 (1.44–1.56) **

  T1

Reference

Reference

Reference

Reference

  T2

1.22 (1.10–1.35) **

1.57 (1.43–1.73) **

1.22 (1.10–1.35) **

1.54 (1.40–1.69) **

  T3

1.63 (1.45–1.83) **

3.07 (2.77–3.41) **

1.66 (1.47–1.86) **

3.04 (2.74–3.38) **

  P trend

 < 0.001

 < 0.001

 < 0.001

 < 0.001

  Low

Reference

Reference

Reference

Reference

  High

1.69 (1.47–1.94) **

2.91 (2.58–3.29) **

1.72 (1.50–1.98) **

2.91 (2.58–3.29) **

  1. aModel 1: unadjusted;
  2. bModel 2: adjusted for age, SBP, smoking, hypertension, family history of DM, current antilipidemic medication, current antihypertensive medication
  3. Compared with NG, **P < 0.01